AnalystsMatthew EcklerMatthew Eckler's Stock Forecasts
AnalystsMatthew Eckler
Sectors:
Analyst Ranking
Bottom 16%
#3878 out of 4573 analysts
Average Return
-19.7%
Win Rate
33%2 out of 6
Risk vs Reward
Poor
Good
Matthew Eckler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunogen IncIMGN | +50.53% | $7.48 | $11.26 | 2017-07-05 - 2018-07-06 | Buy |
Spark Therapeutics IncONCE | +0.24% | $81.88 | $82.08 | 2017-09-14 - 2018-07-19 | Buy |
Matthew Eckler Analyst Color
Get additional color on Matthew Eckler's coverage of popular stocks
Matthew Eckler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dynavax Technologies CorpDVAX | 2 | Buy | $250.00 | N/A | Maintains | 5 years ago |
Spark Therapeutics IncONCE | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Inovio Pharmaceuticals IncINO | 1 | Buy | $132.00 | N/A | Initiates Coverage On | 7 years ago |
Abeona Therapeutics IncABEO | 1 | Buy | $575.00 | N/A | Initiates Coverage On | 7 years ago |
Immunogen IncIMGN | 1 | Buy | N/A | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.